| Date Filed | Type | Description |
| 10/04/2023 |
4
| Coiante Scott M (CFO) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 10/02/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
3
| Coiante Scott M (CFO) has filed a Form 3 on AGILE THERAPEUTICS INC |
| 08/22/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/30/2023 |
4
| Welsh Amy (Chief Commercial Officer) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 13,500 shares
@ $0
Granted 4,500 options to buy
@ $2.48, valued at
$11.2k
|
|
| 06/30/2023 |
4
| Korner Paul (Chief Medical Officer) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 13,500 shares
@ $0
Granted 4,500 options to buy
@ $2.48, valued at
$11.2k
|
|
| 06/30/2023 |
4
| ALTOMARI ALFRED (CEO) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 37,500 shares
@ $0
Granted 8,963 shares
@ $0
Granted 12,500 options to buy
@ $2.48, valued at
$31k
|
|
| 06/30/2023 |
4
| Conway Robert G (Chief Supply Chain Officer) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 13,500 shares
@ $0
Granted 4,500 options to buy
@ $2.48, valued at
$11.2k
|
|
| 06/30/2023 |
4
| Gilmore Geoffrey (Chief Administrative Officer) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 13,500 shares
@ $0
Granted 6,716 shares
@ $0
Granted 4,500 options to buy
@ $2.48, valued at
$11.2k
|
|
| 06/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/09/2023 |
4
| Torrente Josephine (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 06/09/2023 |
4
| Fischer Seth H. Z. (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 06/09/2023 |
4
| Hubbard John W (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 06/09/2023 |
4
| Carson Sandra (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 06/09/2023 |
4
| BARBARI SHARON (Director) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 935 shares
@ $0
Granted 1,065 options to buy
@ $3.58, valued at
$3.8k
|
|
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...|
Docs:
|
"Form of Series C-1 warrant",
"Form of Series C-2 warrant",
"Form of Series D Pre-funded warrant",
"Form of Placement Agent warrant",
"Form of Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A-1 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series A-2 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor",
"Form of Amended and Restated Series B Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor" |
|
| 05/25/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/25/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/25/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/24/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 05/23/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/19/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/17/2023 |
8-K
| Other Events Interactive Data |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/26/2023 |
8-K
| Quarterly results |
|